Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA OKs over-the-counter version of Merck overactive bladder drug
Reuters
Friday, January 25, 2013 - 11:57am
tags:
FDA, Merck, overactive bladder, Oxytrol
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Friday, January 25, 2013 - 11:05am
tags:
CETP inhibitors, Merck, Anacetrapib, Torcetrapib, Pfizer, Roche, dalceptrapib
Should Gilead's quad pill get an exclusivity extension from FDA?
Fierce Pharma
Friday, January 25, 2013 - 10:44am
tags:
Quad, Gilead, FDA, HIV
Novartis Board Was Shocked by Vasella’s Decision to Leave
Bloomberg
Friday, January 25, 2013 - 10:43am
tags:
Novartis, Daniel Vasella
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Friday, January 25, 2013 - 10:39am
tags:
Vivus, Theravance, Roche, MAP Pharmaceuticals, M&A, Immunogen, GSK, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan
Novartis Under U.S. Investigation for Tekturna Marketing
Bloomberg
Friday, January 25, 2013 - 10:13am
tags:
Novartis, Tekturna
It's official: Watson changes name to Actavis
Drugstore News
Friday, January 25, 2013 - 10:12am
tags:
Actavis, Watson Pharmaceuticals
Novartis CEO tempers talk of Roche stake sale
Yahoo/Reuters
Friday, January 25, 2013 - 10:11am
tags:
Novartis, Roche, M&A, Joe Jimenez
Geron Corporation's Recent Catalysts
Seeking Alpha
Friday, January 25, 2013 - 10:09am
tags:
Geron
Boehringer’s Lung Drug’s Benefits Questioned
Bloomberg
Friday, January 25, 2013 - 10:08am
tags:
Boehringer Ingelheim, olodaterol, COPD
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Friday, January 25, 2013 - 8:15am
tags:
Allergan, Keryx, MAP Pharmaceuticals, Threshold Pharmaceuticals
Former shareholder sues NuVasive for $660k in missed milestones payments
Mass Device
Thursday, January 24, 2013 - 10:24pm
tags:
NuVasive, Milestone, legal, lawsuit, devices
Medtronic lands new EU indications for Complete SE stent
Mass Device
Thursday, January 24, 2013 - 10:23pm
tags:
Medtronic, EU, stent, regulatory, devices
Bausch + Lomb lands Class I recall status after broken syringes harm patients
Mass Device
Thursday, January 24, 2013 - 10:23pm
tags:
recall, regulatory, devices, Syringe, patients
FDA abandons off-label marketing protection ruling
Mass Device
Thursday, January 24, 2013 - 10:22pm
tags:
FDA, regulatory, devices
ReCor Medical snags CE mark for next-gen renal denervation
FierceMedicalDevice
Thursday, January 24, 2013 - 10:17pm
tags:
ReCor Medical, devices, CE Mark
Medtronic creeps toward FDA nod for drug-eluting balloon
FierceMedicalDevice
Thursday, January 24, 2013 - 10:16pm
tags:
Medtronic, FDA, drug-eluting, balloon, devices
Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse™ Brachytherapy Treatment Planning Software
Yahoo/PRNewswire
Thursday, January 24, 2013 - 10:13pm
tags:
Varian Medical, FDA, Vitesse, devices
St Jude Medical Earnings Call Nuggets: the FDA Warning Letter and This Year’s Guidance Approach
Wall Street Cheat Sheet
Thursday, January 24, 2013 - 10:13pm
tags:
St. Jude Medical, earnings, FDA
Boston Scientific Fourth Quarter Earnings Sneak Peek
Wall Street Cheat Sheet
Thursday, January 24, 2013 - 10:12pm
tags:
Boston Scientific, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.